Category Archives: Presentations Abstracts

Presentations Abstracts

National(*) , Regional(**) or International(***) Research (PA-x)

** 1. Cooper JW, Honigberg IL. Synthesis of Cyclic Amino Acids, Southeastern Medicinal Chemistry Society, Athens, March 1967.

* 2. Cooper JW, Fish K, Wellins I and Loomis M, “A Seven Nursing Home Study of the Incidence of Potential Drug Interactions,”to Academy of General Practice, APhA, August, 1974, Chicago, Illinois, Proceedings.

* 3. Walchle RC, Cooper JW, “Incidence of Potential Drug Related Problems in Patients Entering a Small Community Hospital,” to Academy of General Practice, APhA, August, 1974, Chicago, Illinois, Proceedings.

* 4. Cooper JW, “Continual Clinical Pharmacy I: A Method to Detect Drug Related Problems in the Small Community,” to the American College of Clinical Pharmacology, May, 1975, Atlantic City, NJ

* 5. Cooper JW, Campbell NA, “Community Hospital Practitioner Consultation,” to Academy of General Practice, APhA, July, 1973, Boston, Massachusetts, Proceedings.

* 6. Cooper JW, “Ideas That Work in the LTCF,” American Pharmaceutical Association Annual Meeting, Academy of General Practice, Long Term Care Section, May 17, 1977, New York, New York, Proceedings.

* 7. Lewis KP, Cooper JW, McKercher PL, “Pharmacist Effect on Digoxin Usage and Toxicity,ASHP Mid Year Clinical Meeting, December 8,1976, Anaheim, California, Proceedings. NOTE; KP Lewis was awarded the ASHP Student Research award in 1977

* 8. Walchle RC, McKercher PL, Cooper JW, “Patient Drug Histories by Criterion Selection,ASHP Annual Meeting, May 18, 1977, New York, New York, Proceedings.

* 9. Birmingham BK, Rhodes CT, Green DS, Cooper JW, “Percutaneous Absorption of Salicylic Acid in Rabbits,” Academy of Pharmaceutical Sciences, May 16, 1977, New York, New York, Proceedings.

* 10. Cooper JW, “Real World Drug Problems of the Elderly Patient,”Invitational Paper to Workshop on Pharmacology and Aging, National Institutes of Health and Aging, September 15, 1977, Proceedings.

* 11. Cooper JW, “Iatrogenic/Self Induced Hyperkalemia in an Elderly Female,” to Academy of Pharmacy Practice, May 17, 1978, Montreal, Canada,Proceedings.

* 12. Cooper JW, “Consultant Pharmacist Effect on Drug Usage in the Long Term Care Facility,” American Society of Consultant Pharmacists Annual Meeting, November 2, 1978, Atlanta, Georgia, Proceedings.

* 13. Williamson DH, Cooper JW, Kotzan JA, “Consultant Pharmacist Effect on Antihypertensive Therapy in the Long Term Care Facility,” American Society of Hospital Pharmacists Mid Year Clinical Meeting, December 5, 1978, San Antonio, Texas, Proceedings.

* 14. Cooper JW, “Drug Regimen Review in the Elderly Patient,” American Society of Consultant Pharmacists, November 16, 1979, Dallas, Texas, Proceedings.

* 15. Wilcher DE, Cooper JW, “Consultant Pharmacist Effect on Analgesic Antiinflammatory Usage in Geriatric Long Term Care Facility,” ASHP Mid Year Clinical Meeting, December 3 4, 1979, Las Vegas, Nevada,Proceedings.

* 16. Tsai A, Cooper JW, McCall CY, “Consultant Pharmacist Effect on Hematopoietic and Vitamin Therapy in a Geriatric Long Term Care Facility,” ASHP Mid Year Clinical Meeting, December 3 4, 1979, Las Vegas, Nevada, Proceedings.

* 17. Lawler RS, Cooper JW, Kotzan JA, “Consultant Pharmacist Input to Treatment of Urinary Tract Infections in a Geriatric Long Term Care Facility,” presented to ASHP Mid Year Clinical Meeting, December 3 4, 1979, Las Vegas, Nevada, Proceedings.

* 18. Cooper JW, Francisco GE, “Consultant Clinical Pharmacist Effect on Psychotropic Usage in Long Term Care Facility Geriatric Patients,” ASHP Mid Year Clinical Meeting, December 3 4, 1979, Las Vegas, Nevada, Proceedings.

** 19. Marcantonio SM, Cooper JW, McCall CY, Mandell GL,”Dexamethasone Prevention of Cisplatinum Nausea and Emesis,” 12th Annual Southeastern Regional Conference on Hospital Pharmacy, March 7, 1981.

** 20. Wilcox JT, Francis WR, Francisco GE, Cooper JW, “Drug Information in U.S.Army Hospitals,” ibid.

** 21. Griffin DL, Francis WR, Francisco GE, Cooper JW, “Pharmacist Contribution to Home Health Care,” ibid.

** 22. Pink LA, Cooper JW, Francis WR, McCall CY, “Pharmacist Input to Digoxin Usage and Effect in a Geriatric Long Term Care Facility,” ibid.

* 23. Spruill WJ, Cooper JW, Taylor WS, “Pharmacist Coordinated Pneumonia and Influenza Vaccination Program,” ASHP Mid Year Clinical Meeting, December, 1981, New Orleans, Louisana, Proceedings.
* 24. Griffin DL, Francisco GE, Cooper JW, Francis WR,”The Pharmacist in Home Health Care,” ibid.

* 25. Wade WE, Cobb HH, Cooper JW, “Drug Related Problems in a Geriatric Ambulatory Population”, ASHP Midyear Clinical Meeting, December 1983, Atlanta, Proceedings.

* 26. Cooper JW, McCall CY, Longe RL, Braucher CL,”The Use of Slow Scan Television for Small Group Therapeutics Lectures.” Am J Pharm Ed. 48:80, 1984.

** 27. Durrence CE, May JR, DiPiro JT, Cooper JW. Drug Interactions in Surgical Patients, 15th Annual Southeastern Conference for Hospital Pharmacy, Athens, Georgia, March 1982.

* 28. Cooper JW, “Drug Related Problems in a Geriatric Long Term Care Facility,” 18th Annual ASCP Meeting, Orlando, 1984.

* 29. Cooper JW, Cobb HH, Shepherd MD, “Drug Discards in Two Georgia LTCFs,” ASHP Mid year Clinical meeting, Dallas, Dec.1984.

** 30. Miller MJ, Cooper JW, Erwin WG, “Efficacy of a Transdermal Patch Product in Geriatric Long Term Care Patients with Angina”, Sixteenth Annual Southeastern Conference for Post Graduate Pharmacy Education and Training, (SECPGPET) 1985.

** 31. Morton MR, Cooper JW, Spruill WJ, Fincham JE, “Pnuemococcal Vaccine Efficacy in a Geriatric LTCF Population, ibid. March 1986.

* 32. Cooper JW, “Transdermal Nitroglycerin Efficacy in Ambulatory Geriatric Patients”. ASHP Mid year, New Orleans, December 1985.

* 33. Cooper JW, “Nursing Home Admission Orders and The Consultant Pharmacist” ASCP Meeting, New Orleans, November, 1986.

* 34. Doyal LE, Cooper JW, “Cost Justification of the Clinical Pharmacist in a Community Mental Health Center”, ASHP Mid Year Meeting, Las Vegas, December, 1986.

** 35. Mallet L, Cooper JW, Wade WE. “Anemia Detection, Prevalence and Treatment Outcome in a Geriatric LTCF Population”. Abstract of 17th SECPGPET meeting, March 1987.

* 36. Cooper JW. “Constipation in the Elderly Patient”. ASCP Mid year meeting, San Diego, May, 1987.

* 37. Cooper JW and Department faculty, “Pharmacy Practice Research”, 1980 1987,” to American Association of Colleges of Pharmacy (AACP), Charleston, July 1987.

** 38. Cooper JW, “How to Deal with the Nursing Home Patient” to region III AACP/NABP Meeting, Biloxi, August, 1987.

*** 39. Cooper JW,” The Development of Consultant Pharmacy in the United States of America”, to Second International Conference on Professional Orientation, Valencia, Spain, November 1987.

*** 40. Cooper JW, ” Geriatrics Pharmacy Practice Contribution to Nursing Home Care in The United States of America” to Second International Congress on Geriatric Pharmacotherapy and Nutrition, Alicante Spain, November 1987.

* 41. Morton MR, Cooper JW,” Digoxin Erythromycin Interaction” to ASHP Mid year Clinical Meeting, Atlanta, December 1987.

* 42. Mallet L, Cooper JW, ” Anemia Development Prediction to ibid.

** 43. Cooper JW, “Geriatric Pharmacy Research at the University of Georgia and Medical College of Georgia”, to University System Advances in Geriatrics and Gerontology, Athens, March, 1988.

** 44. Cooper JW, “Drug Related Problems in the Elderly”, to ibid.

* 45. Cooper JW, Consultant Pharmacist Impact in Health Care: Past, Present and Future, to the American Pharmaceutical Association, Atlanta, March, 1988.

* 46. Mallet L, Cooper JW, “Effect of Intensive Pharmacist Rounding on Nursing Home Care”, ASHP Mid Year Clinical Meeting, Dallas TX, December, 1988.

*** 47. Cooper JW, “The Physician and Pharmacist Roles in Geriatric Patient Compliance”, Hawaiian Medical, Pharmacists and Hospital Pharmacists Societies, Honolulu, September 1989.

*** 48. Cooper JW, “Geriatric Pharmacy Education in the USA”, 3rd International Congress on Geriatric Pharmacotherapy, Alicante, Spain, October 1989.

* 49. Morton MR, Spruill WJ, Cooper JW, Fincham JE, Respiratory infections in Nursing Home Patients Receiving Pnuemococcal and Influenza Vaccines, American Geriatrics Society, May, 1990.

* 50. Cooper JW, Jordan TL, Psychotropics and Falls in Nursing Home Patients. ibid.

* 51. Cooper JW, “Psychoactive Drug Effects in a 200 Geriatric Nursing Home Population” to Pharmacy Science Liaisons of The Upjohn Company, February 1990.

** 52. Jordan TL, Cooper JW, “Adverse Events of Psychotropic Drugs in a Geriatric Nursing Home Population” to Southeastern Postgraduate Education Conference, Athens, April 1990 and American Society of Consultant Pharmacists, San Antonio, November, 1990.

** 53. Gordon JE, Cooper JW, “Diabetes Treatment and Complication Outcomes in a Geriatric Nursing Home A Three Year Study”, to ibid.

** 54. Cooper AE, Cooper JW, “Diuretic Usage and Electrolyte Effects in a Geriatric Nursing Home,” ibid.

*** 55. Cooper JW, “The Development of the Doctor of Pharmacy Degree in The United States of America” to Korean Society of Hospital Pharmacists, Seoul, October 1990.

*** 56. Cooper JW, “Consultant Pharmacists Effect on Diabetes Mellitus Treatment Outcomes in Two Nursing Facilities”, American Society Consultant Pharmacists Annual Meeting , Montreal, November, 1991; Georgia Society of Hospital Pharmacists, Atlanta, 1992

* 57. ” Drug Related Costs and The Elderly” to the Senate Special Committee on Aging, Invited Expert Witness Testimony at the request of Senators David Pryor and Wyche Fowler, Atlanta, April 1992.

*** 58. Cooper JW, “Using ‘Prove it’ to Document the Value of Your Clinical Services”, ASCP, Montreal, Canada, November, 1992

*** 59. Cooper JW, “Geriatric Pharmacotherapy Issues in the United States of America”, Fourth International Congress on Geriatric Pharmacotherapy and Nutrition, Valencia, Spain. 1992

*** 60. Cooper JW, Bristol Royal Health Care Trust Department of Pharmacy, “Clinical Pharmacy Services in Acute and Long Term Care”, Bristol, UK, 25 Aug 1992

*** 61. Cooper JW, Bristol and Weston UK Health Care Districts, “Pharmacy Care in the Community: Experience from the USA”, 27 Aug 92

*** 62. Cooper JW, The School of Pharmacy, University of London,”Impact of the Consultant Pharmacist on Health Care”, 2 Sep 92

*** 63. Cooper JW, Royal Pharmaceutical Society of Great Britain, Scottish Headquarters, Edinburgh, Lothian Pharmacy Practice Group, “Consultant Pharmacist Contributions to Health Care in the United States of America”,3 Sep 92.

*** 64. Cooper JW, British Pharmaceutical Conference, Geriatric Pharmacy Association Meeting, Birmingham, ” Remarks on Consultant Pharmacist Activities at All Levels of Care”, 9 Sep 92

* 65. Cooper JW,” Pharmacotherapy of Depression in Nursing Home Patients-15 years of Pharmacoepdemiologic Results”, Am. Soc. of Cons.Pharmacicts, Orlando, November, 1992.

* 66. Cooper JW, “Pharmacotherapy Recommendations from Monthly Drug Regimen Reviews in a Geriatric Nursing Facility: A One-Year Study” to American College of Clinical Pharmacy Meeting, San Diego, CA February, 1994

*** 67. Cooper JW,” Consultant Pharmacy in the United States of America” to the 3rd International Congress On Unit_Dose Distribution Systems, Alicante, Spain, June 1994.

*** 68. Cooper JW, “Drug Concerns in the the Elderly Patient” to ibid.

*** 69. Cooper JW,”Pharmaceutical Care in the United States of America: Practical Outcome Measures” to Universities of Valencia, Alicante, Cordoba, Granada and Seville and Jaen Pharmacists Society, Spain, June 1994.

* 70. Cooper JW, “Consultant Pharmacist Effect on NSAID Gastropathy over a 5-year Period” to ASCP Meeting, November, 1995

* 71. Cooper JW, “COPD Case Study” to ibid.

* 72. Cooper JW, “Oral Antiviral Safety in the Treatment of Herpes Zoster”, ibid.

** 73. McRae A, Cooper JW. “Nonaggressive short-term nutritional supplementation in a nursing home population” to Southeastern Post-graduate Conference. Athens, GA, May 1996.

*** 74. Cooper JW. Fall risk assessment and reduction within the nursing facility, ASCP meeting abstract p.406-7,, Nashville, November 1996.

*** 75. Cooper JW. Psychoactive-associated fall injury assessment, costs and reduction within the nursing facility, ibid., abstract #23.

*** 76. Cooper JW, Chapman N. Fall risk assessment within the hospital setting, ibid., November 1996.

*** 77. Cooper JW. Approaches for reducing psychotropic-related fall injuries in long term care: treatment of anxiety and agitation, ibid.

*** 78. Cooper JW. Pharmaceutical care and the role of the pharmacist in arthritis therapy, ibid.

*** 79. Cooper JW. Reducing psychotropic-related falls and injuries, agitation, aggression and anxiety in geriatric patients, to American Medical Directors Association, Phoenix, February, 1997.

*** 80. Cooper JW. Buspirone conversion effect on reducing psychoactive-associated falls and fall-related injuries and dementia-associated agitation and aggression in long-term care patients to American Geriatrics Society and American Federation for Aging Research 1997 Annual Scientific Meeting, Atlanta, May, 1997.

***81. Cooper JW. A Pharmacoeconomic analysis of buspirone conversion effect on fall and drug costs and agitation management, to the National Association of Directors of Nursing Administration/Long Term Care, Austin, June 1997.

**82. Janampally R, Cooper JW, et al. Evaluation of the treatment of depression and dementia in a geriatric nursing facility, to 28th Southeastern Residency Conference, Athens, May, 1997.
**83. Cooper JW. Diabetes Treatment Outcomes. Tennessee Society of Consultant Pharmacists, Nashville, August, 1997.

**84. Cooper JW. Depression Treatment Outcomes. Tennessee Society of Consultant Pharmacists, Nashville, August, 1997.

**85. Cooper JW. Falls and Agitation Treatment Outcomes. Tennessee Society of Consultant Pharmacists, Nashville, August, 1997.

**86. Cooper JW. Psychoactive medication related falls. Ohio Medical Association, Columbus, August, 1997.

*87. Cooper JW. Reduction of Falls, Injuries and Agitation in the Nursing Home, National Conference of Geriatric Nurse Practitioners, San Francisco, September, 1997.

*** 88. Cooper JW. Fall Risk Assessment and Reduction within The Nursing Facility, World Congress of Gerontology, Adelaide, August, 1997 Accepted, unable to present.

* 89. Cooper JW, Wade WE. Pharmacist interventions regarding NSAID therapy in a geriatric nursing facility. American College of Clinical Pharmacy, Cincinnati, November 1998, Pharmacotherapy 1998;18:1771.and 1999 University System of Georgia Research Symposium, Augusta, March 1999.

*90. Cooper JW. Osteporosis interventions in a nursing facility: calcium intake assessment and supplementation over a one-year period. American Society of Consultant Pharmacists, Seattle, November 1998.

**91. Cooper JW. Secondary Stroke Prevention Interventions in a Nursing facility Population: A One-year Study, 1999 University System of Georgia Research Symposium, Augusta, March 1999.

**92. Cooper JW. Osteoporosis Interventions in a Nursing Facility: Calcium Intake Assessment to ibid.

**93. Cooper JW. Osteoporosis Interventions in a Nursing Facility: Dietary Calcium Supplementation Trial to ibid.

**94. Cooper JW. Osteoporosis Interventions in a Nursing Facility: Pharmacologic Calcium Supplementation Results to ibid.

**95. Cooper JW. Osteoporosis Interventions in a Nursing Facility: Hormone Replacement Results to ibid.
**96. Cooper JW. Osteoporosis Interventions in a Nursing Facility: Alendronate Outcomes to ibid.

**97. Cooper JW. Osteoporosis Interventions in a Nursing Facility: Calcitonin Nasal Spray Outcomes to ibid.

***98. Cooper JW. Reducing geriatric adverse drug reactions in nursing facility patients to American Societies of Health-System Pharmacists (December) and Consultant Pharmacists (November), 1999.

***99. Cooper JW. Drug-associated appetite and weight changes in long-term care residents: a 5-year study, Long-Term Care Visiting Faculty Program, St. Petersburg, November, 1999.

**100. Cooper JW. Prevention of geriatric adverse drug reactions. Grand Rounds via Videoconference to University of Texas Health Center-affiliated hospitals, January, 2000.

**101. Cooper JW. Advances in Fluoroquinolone Therapy to South Carolina Advanced Nurse Practice Institute, Charleston SC, February, 2000

**102. Horner MR, Cooper JW. Psychotropics, Fall and Hospitalization Risk to Southeastern Postgraduate Conference, Athens, April, 2000.

*** 103. Cooper JW. Pharmacoeconomics of Geriatric Pain, to ASCP Meeting, Las Vegas, May, 2000.

*** 104. Cooper JW. Secondary Stroke Prevention in a Nursing Faciliy Population:A One-Year Study to the American Geriatrics Society/.American Federation for Aging Research Meeting, Nashville, May 2000

*** 105. Cooper JW. Special Drug Considerations in the Geriatric Patient, Lamda Kappa Sigma National Meeting, Houston, August 2000 (4 hours)

**106. Cooper JW. Safe medication use for the older adult (3 hours) to Northeast Georgia Medical Senior Wellness Seminar, Gainesville, June, 2000.

** 107. Cooper JW. Avelox in URTIs, Atlanta, March, 2000.

*108. Cooper JW. Hypolipdemic therapy, Columbus, February, 2000.

*** 109. Cooper JW. Pinnacle Award Acceptance Speech, Canadian Embassy, Washington, DC, June, 2000.
** 110. Cooper JW. Appropriate analgesic treatment in the older adult., GPhA meeting, Amelia Island, Florida, June, 2000.

**111. Cooper JW. Improving medication use in seniors. Savannah area professional groups, July, 2000.

** 112. Cooper JW. Geriatric Research Update. American Medical Directors Association, Georgia Chapter meeting, Callaway Gardens, July, 2000.

** 113. Cooper JW. Optimal Pain management for the geriatric patient. Miss. Soc. Cons. Pharm., Jackson, October, 2000.

***114. Cooper JW. Interactive case management of pain in the senior care patient. American Society of Consultant Pharmacists (ASCP), Boston, November, 2000 (videotape and slides to be online at ASCP.com)

***115. Cooper JW. New advances in treatment of type 2 diabetes mellitus. Ibid. speaker and panel moderator.

***116. Cooper JW. Treatment of depression in geriatric nursing facility residents. Ibid. speaker and session moderator.

***117. Cooper JW. NSAID interventions in senior care recipients to ASCP, November, 2000.

*** 118. Cooper JW. Are beta blockers more poorly tolerated in the elderly patient? Invited presentation to industry advisory panel at the American Heart Association meeting, New Orleans, November 2000.

***119. Cooper JW, Horner MR. Psychotropic load, falls and hospitalization. Amer. Soc.
Health Sys Pharm Mid-year clinical meeting, Las Vegas, December, 2000, abstract 511E

*** 120. Cooper JW. NSAID and platelet-affecting interventions in geriatric patients to ibid.

*** 121. Cooper JW. Drug treatment issues in patients with dementia. Invited participant to Joint Conference on Legal and Ethical Issues in the Progression of Dementia, UGa Law School, December, 2000.

** 122. Cooper JW. Reducing Psychotropic-related falls in nursing facility residents. Georgia geriatrics Society, Atlanta, January 2001 and Ga. ASCP Chapter, February, 2001.

**123. Cooper JW. Drug-related Problems in Older Adults-Consulting ooportunities for Pharmacists, to Michigan Pharmacists Association, Dearborn, MI, February, 2001

*** 124. Cooper JW. Psychotropic Issues in Geriatric Patients, to National Psychiatric Practitioners Conference, Athens, GA, February, 2001

*** 125. Cooper JW. Psychotropic Polypharmacy Case Management to ibid.

** 126. Cooper JW. Pain management for the older adult. Florida Pharmacists Association, Destin, February, 2001.

***127. Cooper JW. Safe Medication Use in the Older Adult. American Pharmaceutical Association, San Francisco, March, 2001

***128. Cooper JW. Drug-related Problems in an Ambulatory Adult Day Care and Senior Citizen Center Population, ibid.

***129. Cooper JW, Wade WE. Pharmacist intervention in geriatric NSAID usage: Outcomes, to Drug Information Association, Savannah, March 2001

** 130. Cooper JW. Adverse drug reactions in a medicaid population. Georgia medical Care Foundation, Atlanta, March, 2001.

** 131. Cooper JW. Liver function tests and assessment in a geriatric population. Wisconsin Society of Pharmacists , April, 2001.

** 132. Cooper JW. Medication assessment and use in dementia. Alzhiemers Assocation of Georgia, Atlanta, February, 2001.

**133. Cooper JW. Encouraging safe medication use in assisted living residents. Huntcliffe Summit, Atlanta, April, 2001.

*** 134. Cooper JW. Pain management in the cognitively impaired adult. American Society of Consultant Pharmacists, Washington, DC, May 2001.

**135. Cooper JW. Behavioral management and psychotropic drugs in dementia. Kentucky Long-Term Care Nurses Association, Louisville, KY, May 2001.

**136. Cooper JW. Fall and osteoporosis risk intervention. Pharmerica conference, Hendersonville, KY, June, 2001.

**137. Cooper JW. Fall prevention in the elderly. Kentucky Pharmacists Association, Lexington, and Ga. ASCP chapter, Atlanta, June, 2001.

*** 138. Cooper JW. Pain management issues in the older adult. Joint Commission on Accreditation of Health Care Organizations Pain Summit, Phoenix, AZ, June, 2001.

***139. Cooper JW. Assessment and treatment of non-malignant pain in the older adult. Grand Rounds, Howard University School of Medicine, Washington, DC, May, 2001.

** 140. Cooper JW. Fall and injury prevention in nursing facility residents. SC ASCP chapter, Columbia, July, 2001. And Auburn CE Programs, August, 2001.

**141. Cooper JW. Safe medication use for the older adult. Colorado Pharmacists Assoc. August and Iowa Pharmacists, September, 2001.

***142. Cooper JW. Perioperative pain management outcomes. American College of Surgeons, New Orleans, October, 2001.

***143. Cooper JW. Development of safe medication use systems for adults. National Community Pharmacists Association, Philadelphia, October, 2001.

***144. Cooper JW. Osteoporosis, falls and injury interventions. Mississippi Society of Consultant Pharmacists, Jackson, October, 2001.

***145. Cooper JW. Pain management in palliative care. ASCP, Chicago, November, 2001.

***146. Cooper JW. Advanced concepts in geriatric problem solving. ASCP, Chicago, November, 2001.

**147. Cooper JW. Infectious disease overview. Mercer University School of Medicine, family practice dept. Grand Rounds, Macon, September, 2001.

***148. Cooper JW. Psychotropic management issues in the geriatric patient. American Society of Health-System Pharmacists, New Orleans, December, 2001.

***149. Cooper JW. Drug-related problems in older adults- consulting opportunities for pharmacists to ibid.

***150. Cooper JW. Cardiovascular implications and COX-2s to Managed Health Care Associates at ASHP meeting, New Orleans, December, 2001.

** 151. Cooper JW. Safe Medication Use in the Older Adult. Sunrise Assisted Living Caregivers, Atlanta, 7 Jan 02.

**152. Cooper JW. Preventing Medication Errors in Long Term Care. Sunscript LTC Meeting, Atlanta, 15 Jan 02.

**153. Cooper JW. Improving drug use in assisted living residents. Legacy link, Gainesville, Ga 7 Feb 02.

**154. Cooper JW. Advanced concepts in geriatric drug therapy problem-solving. Georgia AMDA meeting, Marietta, GA 16 Feb 02.

155. Cooper JW. Pain Management in Cognitively Intact and Impaired Older Adults. Macon Pharmacists Association, 28 Feb 02.

***156. Cooper JW. Development of Medication Management Systems for Assisted Living and Nursing Facility Patients, American Pharmaceutical Association, Philadelphia, 18 Mar 02.

***157. Cooper JW. Drug-related problems in older adults. ibid, 18 Mar 02.

**158. Cooper JW. Special drug considerations in older adults (4.5hrs) to Michigan Pharmacists Association, 22 Feb 02.

**159. Cooper JW. Advanced concepts in older adults pharmacotherapy problem-solving (6 hrs). Pharmacy Society of Wisconsin, 9 Apr 02.

**160. Cooper JW. Falls and incontinence to Pharmerica Nursing home nurses, Macon, 22 Apr 02.

**161. Cooper JW. Osteoporosis Interventions by the pharmacist. Tennessess Pharmacists Association, Knoxville, 14 May, 19 and 26 June 02.

**162. Cooper JW. Fluoroquinolones in respiratory and urinary tract infections. Grady Hospital Pharmacy Clinical Staff, Atlanta, 23 May 02.

*163. Cooper JW. Therapeutic advances in COX-2 selective therapy, Georgia Pharmacists Association, Panama City, 8 June 02.

*164. Cooper JW. Safe medication use in the older adult project, Georgia Pharmacists Association, Panama City, 8 June 02 and 7 Ga. Citiies over June-Sep 2002.

* 165. Cooper JW. Safe medication use in the older adult, Georgia Department of Human Resources, Division of Aging Services, 13 June 2002.

166. *Cooper JW. ADR Intervention in nursing facility patients. Georgia AMDA, ASCP and NADONA Chapters, Reynolds Plantation, GA 12 June 2002.

167. **Cooper JW. Dementia- Delirium-Depression Assessment and Treatment in Nursing Home Patients- Outcomes. Auburn Geriatrics Symposia, Gulf Shores, AL and Lake Guntersville, AL, Julu and August 2002.

168. **Cooper JW. Falls and Urinary Incontinence. Maryland ASCP Chapter, Rocky Gap, 10 Aug 2002.

169. **Cooper JW. Advanced Problem Solving in Geriatric Patients. Mississippi Society of Consultant Pharmacists (6 hrs.). Jackson, 27 Sep 02.

170.*** Cooper JW. Cultural and cognitive differences in pain management. ASCP, Anaheim, 13 Nov 02.

171. * Cooper JW. Infectious disease treatment in geriatric patients. Samford University Geriatrics symposium.(3 hrs) 17 Nov 02.

172. Cooper JW. Practical Pain Management for older adults. Eldercare pharmacists, Augusta, 6 Dec 02.

173. Cooper JW. Practical Pain interventions in elderly patients. ASHP Mid-year Clinical meeting, Atlanta, 11 Dec 02.

NOTE-averaged 70-120 similar local to regional presentations/year 2003-7.

*National;**Regional; ***International Presentation; Otherwise, Local to State Presentation Other invited Lectures and Seminars (past available on request)-over 1200 presented to pharmacy, nursing, physician, gerontology, consumer, industry as well as interdisciplinary groups in 46 of 50 states and 7 countries outside USA over past 30 years.